| 479-98-1 Basic information More.. |
Product Name: | Aucubin | Synonyms: | AUCUBIN;AUCUBOSIDE;B-D-GLUCOPYRANOSIDE, (1S,4AR,5S,7AS)-1,4A,5,7A-TETRAHYDRO-5-HYDROXY-7-(HYDROXYMETHYL)CYCLOPENTA[C]PYRAN-1-YL;(2S,3R,4S,5S,6R)-2-((1S,4Ar,5R,7as)-5-hydroxy-7-hydroxymethyl-1,4A,5,7A-tetrahydro-cyclopenta[C]pyran-1-yloxy)-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol;Aids031379;Aids-031379;Nsc407293;b-D-Glucopyranoside, 1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-1-yl, [1S-(1a,4a,5a,7a)] | CAS: | 479-98-1 | MF: | C15H22O9 | MW: | 346.33 | EINECS: | 207-540-8 | Mol File: | 479-98-1.mol | |
- Aucubin
-
- US $0.00 / g
- 2024-06-03
- CAS:479-98-1
- Min. Order: 1g
- Purity: 98% HPLC
- Supply Ability: 1000kg
- Aucubin
-
- US $0.00 / mg
- 2023-02-24
- CAS:479-98-1
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
- Aucubin
-
- US $15.00-10.00 / KG
- 2021-07-02
- CAS:479-98-1
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
|
479-98-1
Recommend Suppliers |
Company Name: |
Labnetwork lnc.
Recommend
Complaint |
|
Tel: |
+86-27-50766799 |
FAX: |
|
Email: |
contact@labnetwork.com |
Nationality: |
China |
Products Intro: |
Product Name:(2S,3R,4S,5S,6R)-2-[[(1S,4aR,5S,7aS)-5-hydroxy-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol CAS:479-98-1 Purity:95% Package:100g; 1kg Remarks:LN01344819 |
CB Index: |
58 |
WebSite: |
www.labnetwork.com |
Related Information: |
Sales Network
Catalog(19994)
User Evaluation
|
|
|
|
|
Company Name: |
Amadis Chemical Company Limited
Recommend
Complaint |
|
Tel: |
571-89925085 |
FAX: |
0086-571-89925065 |
Email: |
sales@amadischem.com |
Nationality: |
China |
Products Intro: |
Product Name:2-[[(1S,4aR,5S,7aS)-5-hydroxy-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-1-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol CAS:479-98-1 Purity:0.97 Package:mgs,gs,kgs Remarks:A827419 |
CB Index: |
58 |
WebSite: |
http://www.amadischem.com |
Related Information: |
Sales Network
Catalog(131980)
User Evaluation(2)
|
|
|
|
|
|